The Research We Fund

print  Print this page

Research saves lives. Strategic investment in lung cancer research will ensure patients the same promise that is now available for breast, prostate, colorectal, and other cancers — earlier detection, more effective treatment options, higher quality of life, and thousands of lives saved.

LUNGevity invests in the most promising lung cancer research from across the country to improve the survival rate, which is currently at only 17% at 5 years after diagnosis. Better diagnostics to find the cancer early and more effective treatments not only will help more people survive, but will enable them to live well with lung cancer.

LUNGevity invests in research in both early detection and targeted therapeutics. By finding the disease earlier and treating it more effectively, we can achieve our vision of a world where no one dies of lung cancer.

What We Fund

LUNGevity-funded researchers are working on finding a better way to detect, diagnose, and treat lung cancers and prevent their recurrence.

LUNGevity funds biomarker-based, translational research to move knowledge as quickly as possible from basic discovery to treating patients.